BPC-157 has been shown to promote tissue repair, reduce inflammation, improve blood flow, accelerate healing in joints and tendons, and support recovery from injury
No therapeutic, prophylactic, or diagnostic application is claimed or implied, and the peptide is not approved for human or veterinary use in Australia
Yes, it's generally safe when used as prescribed
In my clinical experience, patients with tendinopathy lasting 6-24 months often report: Significant pain reduction by week 2-3 Improved load tolerance during physical therapy by week 4-6 Return to prior activity levels (with appropriate rehab) by week 10-14 Ligament Injuries Partial ligament tears (ankle sprains, knee MCL/LCL sprains, wrist sprains) often leave residual instability and chronic pain
TONY CAVALERO FIRST started thinking about BPC-157 in 2024 in a haze of professional panic